MedPath

Efficacy of vatsnabhadi lepa in comparison with eusol in dushta vrana

Phase 3
Not yet recruiting
Conditions
Complication of surgical and medical care, unspecified. Ayurveda Condition: DUSHTAVRANAH,
Registration Number
CTRI/2025/05/087933
Lead Sponsor
Dr Kalyani Anil Deshmukh
Brief Summary

Infected wound is one of the major contributor to morbidity and mortality

World wise annually 2 million cases concern annually worldwide. Each year it is

to estimated that infected wound developed in 2%-5% of the 16 million

patients undergoing surgical procedure. In developing countries where

resources are scarce is problem is aggravated. In Vatsnabhadi lepa indivisually

all drug has been tested for their different properties but no previous study

has done for this formulation. This study plan to access the efficacy of

vatsnabhadi lepa in management of dushta vrana.

Among all the Mahavisha, Vatsanabha has its own importance. It is the only

Mahavisha that is still recognised and available. Compounds containing

Vatsanabha are enlisted as essential medications for Ayurveda dispensaries

operated under centrally supported programmes of the government of India

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Patient having infected wound.
  • Wound size 1 × 1 cm to 8 × 8cm.
  • Infected wound due to trauma & accident with foul smell and pus discharge.
  • Post- operative all infected wound.
  • Diabetic Mellitus.
Exclusion Criteria
  • Gangrenous wound.
  • Neo-plastic ulcer.
  • Burn, Arterial ulcer, Gout, Renal failure.
  • Liver failure.
  • Varicose ulcer.
  • HIV & Immuno-compromised patients.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Treatment will continue till signs of shudhavrana are seen 3 weeksTreatment will continue till signs of shudhavrana are seen | 3 weeks
Secondary Outcome Measures
NameTimeMethod
To observe the duration required for achieving Shuddha AvasthaTo see the adverse effect of vatsnabhadi lepa dressing during the treatment

Trial Locations

Locations (1)

Sane guruji arogya kendra Hadpsar pune

🇮🇳

Pune, MAHARASHTRA, India

Sane guruji arogya kendra Hadpsar pune
🇮🇳Pune, MAHARASHTRA, India
Dr Kalyani Anil Deshmukh
Principal investigator
8554852673
kavdeshmukh@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.